Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study

European Journal of Cancer Care
P HerasD Mitsibounas

Abstract

Anaemia is common in patients receiving chemotherapy, causing symptoms that have a major impact on quality of life (QoL). Epoetin beta rapidly increases haemoglobin (Hb) levels and improves QoL in anaemic patients with a variety of tumours. This was a randomized, double-blind, parallel-group, dose-finding study assessing the efficacy and safety of once-weekly epoetin beta in patients with solid tumours receiving chemotherapy. Adult patients with anaemia (Hb < 11 g/dL) were randomized to receive epoetin beta 30,000 IU or 20,000 IU once weekly for 12 weeks. All patients received oral iron supplementation. Haemoglobin levels, transfusion need and QoL [Functional Assessment of Cancer Therapy-fatigue (FACT-F) subscale score] were assessed at regular intervals. Fifty patients were randomized; 30 patients received epoetin beta 30,000 IU once weekly and 20 received 20,000 IU once weekly. Mean (+/- SD) increase in Hb from baseline to week 12 was 1.75 +/- 2.15 g/dL in the 30,000 IU group (P = 0.008 vs. baseline) and 1.04 +/- 1.75 g/dL in the 20,000 IU group (non-significant). Haemoglobin response (increase in Hb >or=2 g/dL from baseline) was observed in 78.3% of patients receiving epoetin beta 30,000 IU and 66.7% receiving epoetin beta 2...Continue Reading

References

Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Nov 1, 1988·Psychological Medicine·H M McCormackS Sheather
May 27, 1999·BMJ : British Medical Journal·D Provan
Jul 29, 2000·Cancer Treatment Reviews·S MercadanteS Filosto
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anders OsterborgUNKNOWN Epoetin Beta Hematology Study Group
Aug 24, 2002·BMJ : British Medical Journal·Philip P Mortimer
Apr 2, 2003·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·Jean-Pierre Allain
Apr 3, 2003·British Journal of Cancer·M BoogaertsUNKNOWN Epoetin beta QOL Working Group
Nov 11, 2003·Current Medical Research and Opinion·Nick Bosanquet, Keith Tolley
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerP Soubeyran
Dec 24, 2005·British Journal of Haematology·Christopher A Ludlam, Marc L Turner

❮ Previous
Next ❯

Citations

Dec 16, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Antonio GómezRafael López
May 14, 2010·Cirugía española·Zoilo Madrazo GonzálezAntoni Rafecas Renau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.